Journal of Cardiovascular Pharmacology and Therapeutics

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Google Scholar
Right arrow Articles by Ashikaga, T.
Right arrow Articles by Isobe, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashikaga, T.
Right arrow Articles by Isobe, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 13, No. 1, 58-63 (2008)
DOI: 10.1177/1074248407313397
© 2008 SAGE Publications

Coronary Endothelial Dysfunction and Impaired Microcirculation Response to Atrial Natriuretic Peptide in Hyperinsulinemia

Takashi Ashikaga, MD

Department of Cardiology, Yokohama Minami Kyosai Hospital, ashikaga-ind{at}umin.ac.jp

Mitsuhiro Nishizaki, MD

Department of Cardiology, Yokohama Minami Kyosai Hospital

Hiroyuki Fujii, MD

Department of Cardiology, Yokohama Minami Kyosai Hospital

Kensuke Ihara, MD

Department of Cardiology, Yokohama Minami Kyosai Hospital

Saori Niki, MD

Department of Cardiology, Yokohama Minami Kyosai Hospital

Tadashi Murai, MD

Department of Cardiology, Yokohama Minami Kyosai Hospital

Shingo Maeda, MD

Department of Cardiology, Yokohama Minami Kyosai Hospital

Noriyoshi Yamawake, MD

Department of Cardiology, Yokohama Minami Kyosai Hospital

Yukio Kishi, MD

Center for Preventive Medicine, Tokyo Kyosai Hospital

Mitsuaki Isobe, MD

Department of Cardiovascular Medicine, Tokyo Medical and the Dental University Japan

Endothelial dysfunction occurs in hyperinsulinemia (HI). Coronary microcirculation responses to vasoactive agents are examined in 57 patients with angiographically normal coronary arteries. Patients were divided into 2 groups, 37 with normoinsulinemia (NI) and 20 with HI based on results of a 75-g oral glucose tolerance test. Epicardial artery vasoactivity in response to acetylcholine chloride is measured to assess endothelial function. Coronary microcirculation function is evaluated by intracoronary administration of 50 µg of adenosine triphosphate, 1 mg of isosorbide dinitrate, and 0.05 mg/kg of atrial natriuretic peptide. Epicardial artery vasoconstriction in response to 100 µg of acetylcholine is mildly reduced in HI (P = .04). Coronary flow reserve in response to adenosine triphosphate in NI is similar to that in HI. In NI, the resting mean (SD) peak velocity in response to isosorbide dinitrate (40.7 [10.9] cm/s) vs atrial natriuretic peptide (39.6 [10.9] cm/s) is similar. In contrast, the resting mean (SD) peak velocity in response to atrial natriuretic peptide (31.3 [9.3] cm/s) vs isosorbide dinitrate (43.5 [10.0] cm/s) in HI is statistically significantly blunted (P < .001). Atrial natriuretic peptide may have a pathologic effect on coronary microcirculation even in mild endothelial dysfunction among patients with HI.

Key Words: atrial natriuretic peptide • endothelial dysfunction • hyperinsulinemia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?